tirzepatide systematic review Efficacy and safety of for treatment of overweight or obesity. A and meta-analysis Tirzepatide and autoimmune disease: what
Description
Who should consider alternatives Given the emerging safety data, several groups should particularly consider switching to a B12-free tirzepatide formulation with separate B12 supplementation
In a recent study, participants who took tirzepatide lost an average of 12.4% of their body weight over 72 weeks
tirzepatide, n = 31
Retrieved from Lilly-f
For sweeteners, choose monk fruit or allulose to avoid blood sugar spikes
Retrieved from Mathew, P
